Notice of Correction to Key Dates for PAR-19-282 " Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)"

Notice Number: NOT-DA-19-049

Key Dates
Release Date: June 6, 2019

Related Announcements
PAR-19-282

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice is to inform potential applicants of corrections to the Council Review Dates for PAR-19-282 " Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)".

The FOA has been modified as follows:

Part 1. Overview Information

Key Dates

Currently Reads:

Advisory Council Review

May 2020, January 2021, October 2022, May 2022, January 2023, October 2023

Modified to Read:

Advisory Council Review

May 2020, January 2021, October 2021, May 2022, January 2023, October 2023

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Vani Pariyadath, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: (301) 443-3209
Email: vani.pariyadath@nih.gov